Abstract
This chapter is written as a general guide for the interested reader in the pharmacology of the respiratory system; thus, there are topics that necessarily overlap with the pharmacology of organs covered in other chapters. For example, the general stimulatory effect on respiration resulting from administration of toxic doses of most adrenergic activators is related to their central nervous system effects, as discussed in Chap. Sec. II B. A change in resistance to breathing in the upper respiratory tract is mediated by the pharmacologic effects of adrenergic activators on nasal blood vessels. This vascular phenomenon is pharmacologically related to behavior of the peripheral blood vessels, as discussed in Chap. Sec. III, Chap. 5. Any discussion of the pharmacology of the pulmonary circulation must include consideration of pulmonary blood flow or cardiac output, which is, in turn, dependent upon cardiac performance, as discussed in Chap. Sec. III, Chap. 5. More than three-quarters of the total clinical use of adrenergic drugs is in the treatment of diseases of the respiratory system. The pharmacologic basis for antiasthmatic drugs and cold remedies discussed in this chapter should supplement the clinical usage discussed in Chap. Sec. 5, Chap. 5. The remaining one-quarter of the clinical use of adrenergic inhibitors and activators (e.g., vasopressors, antihypertensives, antiarrhythmics, anorexigenics, antispasmodics) is also discussed in this chapter but additional details appear in Chap. Sec. 5, Chap. 5. Thus, these drugs may engender adverse reactions involving the respiratory system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adelson, B.H., Gilbert, R.P.: The effect of levarterenol on the dye-dilution curve in two patients with shock from acute infarction of the myocardium. Q. Bull. Northw. Univ. Med. Sch. 33, 191–193 (1959)
Aellig, W.H.: Experiments with pindolol (Visken) in healthy volunteers. Med. J. Aust. 2 (Suppl. 2), 8–11 (1977)
Anthracite, R.F., Vachon, L., Knapp, P.H.: Alpha-adrenergic receptors in the human lung. Psychosom. Med. 23, 481–489 (1971)
Apperley, G.H., Daly, M.J., Levy, G.P.: Selectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular, and cardiac muscle in the anaesthetized cat. Br. J. Pharmacol. 57, 235–246 (1976)
Aramendia, P., Martinez L. De Letona, J., Aviado, D.M.: Exchange of blood between pulmonary and systemic circulations via bronchopulmonary anastomoses. Circ. Res. 11, 870–879 (1962a)
Aramendia, P., Martinez L. De Letona, J., Aviado, D.M.: Responses of the bronchial veins in a heart-lung bronchial preparation with special reference to a pulmonary bronchial shunt. Circ. Res. 10, 3–10 (1962b)
Areskog, N.H., Cullhed, I., Ringqvist, I., Strom, G.: Cardiovascular and respiratory effects of the ß-adrenoceptive antagonist Sotalol. Studies in health, angina pectoris and obstructive lung disease. Eur. J. Clin. Pharmacol. 8, 403–408 (1975)
Arner, B., Magnusson, P.O.: Comparison between ibuterol hydrochloride and terbutaline in asthma. Br. Med. J. 1, 72–74 (1976)
Arner, B., Bertler, A., Karlefors, T., Westling, H.: Bronchodilator effect of a new sympathomimetic ß-receptor-stimulating agent, terbutaline, given subcutaneously to asthmatic patients. Acta Med. Scand. [Suppl.] 512, 41–43 (1970)
Aviado, D.M.: Sympathetic nerve blocking drugs for the treatment of hypertension. TM-10, Beta Tm-10, Bretylium and guanethidine. Am. J. Med. Sci. 244, 650–661 (1961)
Aviado, D.M.: The lung circulation. Vol. 1. Physiology and pharmacology. Vol. 2. Pathological physiology and therapy of diseases. Vol. 1, pp. 1–590, Vol. 2, pp. 591–1405. Oxford: Pergamon Press 1965
Aviado, D.M.: Pharmacology of hypertension with special reference to the cardiovascular effects of beta-adrenergic blocking agents. In: Advances in cardiopulmonary diseases. Banyai, A.L., Gordon, B.L. (eds.), Vol. IV, pp. 129–143. Chicago: Yearbook Medical 1969
Aviado, D.M.: Sympathomimetic drugs, pp. 1–615. Springfield: Thomas 1970
Aviado, D.M.: Potential hazards of bronchodilator aerosols. Toxicity of aerosols. J. Clin. Pharmacol. 15, 86–104 (1975)
Aviado, D.M.: Adrenergic agents in bronchial asthma, emphasizing undesirable reactions. In: Status asthmaticus. Weiss, E.B. (ed.), pp. 215–223. Baltimore: University Park Press 1978
Aviado, D.M.: Sotalol: A pure beta-adrenergic blocking agent for the treatment of essential hypertension and other cardiovascular diseases. J. Clin. Pharmacol. 19, 497–504 (1979)
Aviado, D.M., De Beer, E.J.: A comparative study of nasal decongestion by sympathomimetic drugs. Arch. Otolaryngol. 69, 598–605 (1959)
Aviado, D.M., Dil, A.H.: Effects of a new sympathetic blocking drug (Bretylium) on cardiovascular control. J. Pharmacol. Exp. Ther. 129, 330–337 (1960)
Aviado, D.M., Schmidt, C.F.: Effects of sympathomimetic drugs on pulmonary circulation with special reference to a new pulmonary vasodilator. J. Pharmacol. Exp. Ther. 120, 512–527 (1957)
Aviado, D.M., Ling, J.S., Schmidt, C.F.: Effects of anoxia on pulmonary circulation: Reflex pulmonary vasoconstriction. Am. J. Physiol. 189, 253–262 (1957)
Aviado, D.M., Wnuck, A.L., De Beer, E.J.: Cardiovascular effects of sympathomimetic bronchodilators: Epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine, and isoprophenamine. J. Pharmacol. Exp. Ther. 122, 406–417 (1958)
Aviado, D.M., De Burgh Daly, M., Lee, C.Y., Schmidt, C.F.: The contribution of the bronchial circulation to the venous admixture in pulmonary venous blood. J. Physiol. (Lond.) 155, 602–622 (1961)
Aviado, D.M., Folie, L.E., Pisanty, J.: The influence of a new adrenergic beta-receptor (MJ1999) blocking drug on the pulmonary circulation. Arch. Int. Pharmacodyn. Ther. 168, 323–338 (1967)
Aviado, D.M., Kishimoto, T., Kneidinger, H.J.: Bronchopulmonary effects of pentaerythrityl tetranitrate and isoproterenol. J. Pharmacol. Exp. Ther. 165, 274–285 (1969)
Aviado, D.M., Wnuck, A.L., De Beer, E.J.: A comparative study of nasal decongestion by sympathomimetic drugs. Arch. Otolaryngol. 69, 598–605 (1959)
Bariety, M., Kohler, D.: Sur l’existence d’un facteur histaminique dans le determinisme de l’oedeme pulmonaire aigu adrenalinque chez le lapin. C. R. Acad. Sci. (Paris) 236, 1389–1391 (1953)
Barnett, D.B., Rugg, E.L., Nahorski, S.R.: Direct evidence of two types of beta adrenoceptor binding site in lung tissue. Nature 273, 166–168 (1978)
Bartsch, P., Reginster, M.: Chronic obstructive lung disease after practolol. Lancet 1, 908–909 (1977)
Baskerville, A.: The development and persistence of bronchial gland hypertrophy and goblet-cell hyperplasia in the pig after injection of isoprenaline. J. Pathol. 119, 35–47 (1976)
Beck, W., Schrire, V., Vogelpoel, L., Nellen, M., Swanepoel, A.: Hemodynamic effects of amyl nitrite and phenylephrine on the normal human circulation and their relation to changes in cardiac murmurs. Am. J. Cardiol. 8, 241–349 (1961)
Beil, M., Ulmer, W.T.: Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease. Arzneim. Forsch. 27, 419–422 (1977)
Beil, M., Brecht, H.M., Rasche, B.: Plasma catecholamines in exercise induced bronchoconstriction. Klin. Wochenschr. 55, 577–581 (1977)
Benson, M.K.: Bronchial responsiveness to inhaled histamine and isoprenaline in patients with airway obstruction. Thorax 33, 211–213 (1978)
Berk, J.L., Hagen, J.F., Koo, R., Maly, G.: Pulmonary insufficiency produced by isoproterenol. Surg. Gynecol. Obstet. 143, 725–726 (1976)
Berk, J.L., Hagen, J.F., Tong, R.K., Levy, M.L., Martin, P.J.: The role of adrenergic stimulation in the pathogenesis of pulmonary insufficiency. Surgery 82, 366–372 (1977)
Bianco, S., Kamburoff, P.L., Prime, F.J.: Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol (“Pulmadil”) and 0.2 mgs salbutamol. Curr. Med. Res. Opin. 3, 30–35 (1975)
Biel, J.H., Schwartz, E.G., Sprengeler, E.P., Leiser, H.A., Friedman, H.L.: Bronchodilators, N-substituted derivatives of 1-(3′4′-Dihydroxyphenyl)-2-aminoethanol (Arterenol). J. Am. Chem. Soc. 76, 3149–3153 (1954)
Boehringer Ingelhein Ltd.: Alupent brand of metaproterenol sulfate. Tablets of 20 ng metered dose inhaler. AL-448, pp. 1–72. Elmsford, N.Y.: Boehringer Ingelheim 1975
Bolduc, P., Reid, L.: The effect of isoprenaline and pilocarpine on mitotic index and goblet cell number in rat respiratory epithelium. Br. J. Exp. Pathol. 59, 311–318 (1978)
Bouhuys, A.: Pharmacological basis for refractoriness. In: Status asthmaticus. Weiss, E.B. (ed.), pp. 49–58. Baltimore: University Park Press 1978
Bowman, W.C., Raper, C.: Sympathomimetic bronchodilators and animal models for assessing their potential value in asthma. J. Pharm. Pharmacol. 28 (Suppl.4), 369–374 (1976)
Brittain, R.T., Jack, D.: Recent work on selective beta-adrenoceptor stimulants. In: Mechanisms and therapeutics. Weiss, E.B., Segal, M.S. (eds.). Boston: Little, Brown and Co. 1976
Bürkmann, I., Heberling, J.H., Herold, B., Kling, K.: Ventilation, gas-exchange, and pulmonary arterial pressure during aerosol inhalation of sympathicomimetics. Z. Erkr. Atmungsorgane 145, 350–353 (1976)
Buhr, G.: Über den Einfluß der Aludrin-Aerosol-Inhalation auf die Druckverhältnisse in der Arteria pulmonalis beim Menschen. Z. Kreisl. Forsch. 42, 669–683 (1953)
Burn, J.H., Rand, M.J.: The action of sympathomimetic amines in animals treated with reserpine. J. Physiol. (Lond.) 144, 314–336 (1958)
Burns, J.W., Doe, J.E.: A comparison of drug-induced responses on rat tracheal, bronchial, and lung strip in vitro preparations. Br. J. Pharmacol. 64, 71–74 (1978)
Busse, W.W.: Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am. Rev. Respir. Dis. 115, 783–791 (1977)
Caplin, I., Haynes, J.T.: Complications of aerosol therapy in asthma. Ann. Allergy 27, 65 (1969)
Carrillo, L., Kishimoto, T., Aviado, D.M.: The nasal and bronchopulmonary effects of xylometazoline and KB 227. Ann. Otol. Rhinol. Laryngol. 78, 415–420 (1969)
Castro de la Mata, R., Penna, M., Aviado, D.M.: Reversal of sympathomimetic bronchodilation by dichloroisoproterenol. J. Pharmacol. Exp. Ther. 135, 197–203 (1962)
Chand, N.: Evidence for the existence of a-adrenoceptors in the rat lung. Res. Commun. Chem. Pathol. Pharmacol. 25, 215–225 (1979)
Chapman, T.T.: Comparison of Carbuterol, a new selective bronchodilator agent, with salbutamol in a single dose cross-over trial. J. Irish Med. Assoc. 69, 113–116 (1976)
Chapman, T.T.: Spasm and secretion in asthma. Br. Med. J. 2, 50 (1970)
Cho, Y.W., Lish, P.M., Aviado, D.M.: Efficacy of a new bronchodilator, soterenol, on experimental locked-lung syndrome in dogs. J. Allergy. 42, 36–48 (1968)
Christensen, J.M., Valasek, F.E., Tainter, M.L.: Ethylnorepinephrine: A unique bronchodilator. American Productioner 9, 916–921 (1958)
Collins, J.V., Clark, T.J., Brown, D.J.: Airway function in healthy subjects and patients with left heart disease. Clin. Sci. Mol. Med. 49, 217–228 (1975)
Combs, A.B., Jones, J.: The action of isoproterenol on phenylthiourea induced pulmonary edema. Res. Conmun. Chem. Pathol. Pharmacol. 12, 177–180 (1975)
Conolly, M.E., Greenacre, J.K.: The beta-adrenoceptor of the human lymphocyte and human lung parenchyma. Br. J. Pharmacol. 59, 17–23 (1977)
Davila, D., Davila, T.: Uptake and release of 3-H-metaraminol by rat lung. Basic aspects, ionic and energy requirements. Arch. Int. Pharmacodyn. Ther. 214, 53–61 (1975)
De Burgh Daly, I., Hebb, C.O., Petrovskaia, B.: Adrenaline bronchoconstriction in isolated blood-perfused lungs. Q. J. Exp. Physiol. 31, 129–159 (1942)
Dresdale, D.T., Michtom, R.J., Schultz, M.: Recent studies in primary pulmonary hypertension including pharmacodynamic observations on pulmonary vascular resistance. Bull. N.Y. Acad. Med. 30, 195–207 (1954)
Drimal, J., Aviado, D.M.: Effects of oxprenolol on coronary circulation and cardiac metabolism. J. Pharmacol. Exp. Ther. 176, 312–319 (1971)
Duncan, P.E., Griffin, J.P., Solomon, S.S.: Bronchodilator drug efficacy via cyclic AMP. Thorax 30, 192–196 (1975)
Eliakim, M., Aviado, D.M.: Effects of nerve stimulation and drugs on the extra-pulmonary portion of the pulmonary vein. J. Pharmacol. Exp. Ther. 133, 304–312 (1961)
Engel, L.A., Landau, L., Taussig, L., Martin, R.R., Sybrecht, G.: Influence of bronchomotor tone on regional ventilation distribution at residual volume. J. Appl. Physiol. 40, 411–416 (1976)
Engelhardt, A., Hoefke, W., Wick, H.: Zur Pharmakologie des sympathomimeticums 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-isopropylaminoäthan. Arzneim. Forsch. 11, 521–525 (1961)
Eriksson, N.E., Lindgren, S.B.: The rapidity of bronchodilation. A comparison of isoprenaline, terbutaline, and rimiterol. Scand. J. Respir. Dis. 59, 30–36 (1978)
Folle, L.E., Aviado, D.M.: Cardiovascular effects of anoxia and the influence of a new beta adrenergic receptor blocking drug. J. Pharmacol. Exp. Ther. 149, 79–90 (1965)
Foster, W.M., Bergofsky, E.H., Bohning, D.E., Lippmann, M., Albert, R.E.: Effect of adrenergic agents and their mode of action on mucociliary clearance in man. J. Appl. Physiol. 41, 146–152 (1976)
Gayrard, P., Orehek, J., Grimaud, C., Charpin, J.: Bronchoconstrictor effects of a deep inspiration in patients with asthma. Am. Rev. Respir. Dis. 111, 433–439 (1975a)
Gayrard, P., Orehek, J., Grimaud, C., Charpin, J.: Beta-adrenergic function in airways of healthy and asthmatic subjects. Thorax 30, 657–662 (1975b)
Gloster, J., Heath, D., Hasleton, P., Harris, P.: Effect of chlorphentermine on the lipids of rat lungs. Thorax 31, 558–564 (1976)
Goldenberg, M., Pines, K.L., Baldwin, E. de F., Greene, D.G., Roh, C.E.: The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension. Am. J. Med. 5, 792–805 (1948)
Gourzis, J.T., Roque, N., Nickerson, M.: Chemical structure and antishock activity among compounds related to phenoxybenzamine (dibenzyline). J. Pharmacol. Exp. Ther. 141, 314–320 (1963)
Grimm, D.J., Dawson, C.A., Hakin, T.S., Linehan, J.H.: Pulmonary vasomotion and the distribution of vascular resistance in a dog lung lobe. J. Appl. Physiol. 45, 545–550 (1978)
Harms, H.H.: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: A comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors. J. Pharmacol. Exp. Ther. 199, 329–335 (1976)
Harms, H.H., Spoelstra, A.J.: Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol, and pindolol in the anaesthetized dog. Clin. Exp. Pharmacol. Physiol. 5, 53–59 (1978)
Hartley, D., Jack, D., Lunts, L.H.C., Ritchie, A.C.: New class of selective stimulants of ß adrenergic receptors. Nature 219, 861–862 (1968)
Hooker, C.S., Calkins, P.J., Fleisch, J.H.: On the measurement of vascular and respiratory smooth muscle responses in vitro. Blood Vessels 14, 1–11 (1977)
Johnsson, G.: Use of beta-adrenoreceptor blockers in combination with beta-stimulators in patients with obstructive lung disease. Drugs 1 (Suppl. 11), 171–177 (1976)
Joiner, P.D., Kadowitz, P.J., Hughes, J.P., Hyman, A.L.: NE and ACh responses of intrapulmonary vessels from dog, swine, sheep, and man. Am. J. Physiol. 228, 1821–1827 (1975)
Junod, A.F.: Mechanism of uptake of biogenic amines in the pulmonary circulation. In: Lung metabolism. Junod, A.F., de Haller, R. (eds.), pp. 387–398. New York: Academic Press 1975a
Junod, A.F.: The lung and the metabolism of vasoactive substances. Schweiz. Med. Wochenschr. 105, 1656–1658 (1975b)
Junod, A.F., Ody, C.: Anine uptake and metabolism by endothelium of pig pulmonary artery and aorta. Am. J. Physiol. 232, C88–94 (1977)
Kaik, G.: Study of the influence of the beta-sympatholytic drug KÖ 1366 (Bunitrolol on lung function). Wien. Klin. Wochenschr. 88, 68–71 (1976)
Karabelnik, D., Zbinden, G.: Drug-induced foam cell reactions in rats. II. Chemical analysis of lipids stored in lungs and foam cells after treatment with chlorphentermine, 5-(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10.393) and 1-chloramitripty-line. Hoppe Seylers Z. Physiol. Chem. 356, 1151–1160 (1975)
Kaufman, A.J., Ochoa, E.: Similar receptors mediating the norepinephrine and dopamine contraction in the main pulmonary artery of the dog. Acta Physiol. Lat. Am. 20, 451–463 (1971)
Kaufman, A.J., Iglauer, A., Herwitz, G.K.: Effect of isuprel (isopropyl-epinephrine) on circulation of normal man. Am. J. Med. 11, 442–447 (1951)
Kealey, G.P., Brody, M.J.: Studies on the mechanism of pulmonary vascular responses to miliary pulmonary embolism. Circ. Res. 41, 807–814 (1977)
Keighley, J.F.: Iatrogenic asthma associated with adrenergic aerosols. Ann. Intern. Med. 65, 985 (1966)
Kneussl, M.P., Richardson, J.B.: Alpha-adrenergic receptors in human and canine tracheal and bronchial smooth muscle. J. Appl. Physiol. 45, 307–311 (1978)
Koch, G.: Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am. Heart J. 93, 585–591 (1977)
Kumana, C.R., Kaye, C.M., Leighton, M., Turner, P., Hamer, J.: Cardiac and pulmonary effects of acebutolol. Lancet 2, 89–93 (1975)
Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P., Brown, T.G.: Differentiation of receptor systems activated by sumpathomimetic amines. Nature 214, 597–599 (1967)
Larsson, S.: Long-term treatment with ß2-adrenostimulants in asthma. Side-effects, selectivity, tolerance, and routes of administration. Acta Med. Scand. [Suppl] 608, 1–40 (1977)
Lippmann, M., Albert, R.E., Yeates, D.B., Berger, J.M., Foster, W.M., Bohning, D.E.: Factors affecting tracheobronchial mucociliary transport. Inhaled Part. 1, 305–319 (1975)
Luisada, A.A.: The pathogenesis of paroxysmal pulmonary edema. Medicine (Baltimore) 19, 475–504 (1940)
Malik, A.B.: Pulmonary vascular response to increase in intracranial pressure: Role of sympathetic mechanisms. J. Appl. Physiol. 42, 335–343 (1977)
Mardel, MJ., Smith, H., Spicer, B.A.: Bronchodilators giving reduced cardiovascular effects. Relative biological activities of the four isomers of 1-(3,4-dihydroxyphenyl)-2-isopropyla-minobutanol. J. Med. Chem. 17, 513–516 (1974)
Marion Laboratories. Ventair. 2 mg Tablets (protokylol HC1) Marion. A drug monograph, pp. 1–54. Kansas City: Marion Laboratories 1974
Marlin, G.E., Turner, P.: The relative potencies and beta 2-selectivities of intravenous rimiterol, salbutamol, and isoprenaline in asthmatic patients. Int. J. Clin. Pharmacol. Biopharm. 12, 158–169 (1975)
Marlin, G.E., Kumana, C.R., Kaye, C.M., Smith, D.M., Turner, P.: An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br. J. Clin. Pharmacol. 2, 151–157 (1975)
Martinez L. De Letona, J., Castro de la Mata, R., Aviado, D.M.: Local and reflex effects of bronchial arterial injection of drugs. J. Pharmacol. Exp. Ther. 133, 295–303 (1961)
Mathé, A.A., Tong, E.Y., Tisher, P.W.: Norepinephrine release from the lung by sympathetic nerve stimulation inhibition by vagus and methacholine. Life Sci. 20, 1425–1430 (1977)
McFadden, E.R. Jr., Ingram, R.H. Jr.: Exercise-induced asthma; observations on the initiating stimulus. N. England J. Med. 301, 763–769 (1979)
Melville, G.N., Horstmann, G., Iravani, J.: Adrenergic compounds and the respiratory tract. A physiological and electron-microscopical study. Respiration 33, 261–269 (1976)
Mentzer, R.M., Alegre, C.A., Nolan, S.P.: The effects of dopamine and isoproterenol on the pulmonary circulation. J. Thorac. Cardiovasc. Surg. 71, 807–814 (1976)
Minette, A., Marcq, M., Gepts, L.: Carbuterol, fenoterol, orciprenaline, salbutamol, and terbutaline per os in reversible obstructive chronic bronchitis. Bull. Eur. Physiopathol. Respir. 12, 545–553 (1976)
Moore, P.F., Constantine, J.W., Barth, W.E.: Pirbuterol, a selective Beta2 Adrenergic bronchodilator. J. Pharmacol. Exp. Ther. 2, 410–418 (1978)
Mossberg, B., Strandberg, K., Philipson, K., Camner, P.: Tracheobronchial clearance in bronchial asthma: Response to beta-adrenoceptor stimulation. Scand. J. Respir. Dis. 57, 119–128 (1976)
Nelson, H.S., Black, J.W., Branch, L.B., Pfuetze, B., Spaulding, H., Summers, R., Wood, D.: Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals. J. Allergy Clin. Immunol. 55, 299–309 (1975)
Nelson, H.S., Raine, D., Jr., Doner, H.C., Posey, W.C.: Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am. Rev. Respir. Dis. 116, 871–878 (1977)
Nickerson, M., Gourzis, J.T.: Blockade of sympathetic vasoconstriction in the treatment of shock. J. Trauma 2, 399–411 (1962)
Niden, A.H., Aviado, D.M.: Effects of pulmonary embolism on the pulmonary circulation with special reference to arteriovenous shunts in the lung. Circ. Res. 4, 67–73 (1956)
Nousiainen, O.T., Arnala, I., Airaksinen, M.M., Kokkola, K.: Potentiation of beta-sympathomimetics with alpha-adrenoceptor blocking drugs in guinea pig trachea and human bronchus preparations. Pharmacology 15, 469–477 (1977)
O’Donnell, S.R., Wanstall, J.C.: The contribution of extraneuronal uptake to the trachea-blood vessel selectivity of ß-adrenoceptor stimulants in vitro in guinea-pigs. Br. J. Pharmacol. 57, 369–373 (1976)
Orange, R.P., Austen, K.F.: Immunological release of the chemical mediators of anaphylaxis, identification of asthma. Ciba Foundation Study Group No. 38. Porter, R., Birch, J. (eds.), pp. 99–110. Edinburgh: Churchill Livingstone 1971
Palmer, K.N.Y., Diemant, M.L.: Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma. Br. Med. J. 1, 31–32 (1969)
Patel, K.R.: Atropine, sodium cromoglycate, and thymoxamine in PGF2 alpha-induced bronchoconstriction in extrinsic asthma. Br. Med. J. 2, 360–362 (1975)
Persson, H., Olsson, T.: Some pharmacological properties of terbutaline (INN), 1-(3.5-Dihydroxyphenyl)-2-(T-Butylamino)-ethanol. A new sympathomimetic ß-receptor-stimulating agent. Acta Med. Scand. [Suppl.] 512, 11–19 (1970)
Phillips, M.A.: Bronchodilator aerosols. Lancet 2, 677 (1967)
Ploy-Song-Sand, Y., Corbin, R.P., Engel, L.A.: Effects of intravenous histamine on lung mechanics in man after beta-blockage. J. Appl. Physiol. 44, 690–695 (1978)
Porcelli, R.J., Viau, A.T., Naftchi, N.E., Bergofsky, E.H.: Beta-receptor influence on lung vasoconstrictor responses to hypoxia and humoral agents. J. Appl. Physiol. 43, 612–616 (1977a)
Porcelli, R.J., Viau, A., Demeny, M., Naftchi, N.E., Bergofsky, E.H.: Relation between hypoxic pulmonary vasoconstriction, its humoral mediators and alpha-beta adrenergic receptors. Chest 71 (Suppl.2), 249–251 (1977b)
Reisman, R.E.: Asthma induced by adrenergic aerosols. J. Allergy 46, 102 (1970)
Renais, J., Scebat, L., Lenegre, J.: Oèdeme pulmonaire expérimental par insuffisance ventriculaire gauche aigue. Arch. Mal. Coeur. 50, 715–719 (1957)
Rhoades, R.B., Leifer, K.N., Bloom, F.L., Wittig, H.J.: Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children. Am. Rev. Respir. Dis. 114, 79–86 (1976)
Roch-Besser, B.: La Benzyl-inidazoline (priscol). Etude pharmacodynamique et applications cliniques. Helv. Med. Acta 17, Suppl. 27, 1–175 (1950)
Rodger, I.W.: Effect of isoetharine on airways resistance, heart rate, and contractions of the soleus muscle of the anaesthetised cat. Eur. J. Pharmacol. 24, 211–217 (1973)
Ryo, U.Y., Townley, R.G.: Comparison of respiratory and cardiovascular effects of isoproterenol, propranolol, and practolol in asthmatic and normal subjects. J. Allergy Clin. Immunol. 57, 12–24 (1976)
Salem, H., Aviado, D.M.: Antitussive drugs with special reference to a new theory for the initiation of the cough reflex and the influence of bronchodilators. Am. J. Med. Sci. 247, 585–600 (1964)
Salem, H., Aviado, D.M.: Preclinical and clinical investigation of drugs. I. Bronchodilators and antiasthmatic drugs. Drug. Inform. Bull. 8, 14–19 (1974)
Sannerstedt, R., Varnauskas, E., Werko, L.: Hemodynamic effects of methyldopa (Aldomet), at rest and during exercise in patients with arterial hypertension. Acta Med. Scand. 171, 75–82 (1962)
Schonell, M., Harris, M., McMiken, D., Jenne, H., Evers, R.: Bronchodilator effect of hexoprenaline aerosol in bronchial asthma and chronic bronchitis. Med. J. Aust. 2, 828–831 (1977)
Schwarz, R.H., Aviado, D.M.: Drug action, reaction, and interaction. III. Dopamine for endotoxic shock. J. Clin. Pharmacol. 16, 88–98 (1976)
Schwitter, E., Février, D., Bachofen, H.: The inhalation of beta stimulators. Effect of the inhaled aerosol deposited in the oropharynx and in the bronchial tree. Schweiz. Med. Wochenschr. 105, 497–499 (1975)
Siegler, D., Fukuchi, Y., Engel, L.: Influence of bronchomotor tone on ventilation distribution and airway closure in asymptomatic asthma. Am. Rev. Respir. Dis. 114, 123–130 (1976)
Skinner, C., Gaddie, J., Palmer, K.N.V.: Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma. Br. Med. J. 2, 59–61 (1975)
Sly, R.M.: Comparison of bronkephrine and epinephrine in the treatment of acute asthmatic attacks in children. Ann. Allergy 27, 384–389 (1969)
Snashall, P.D., Boother, F.A., Sterling, G.M.: The effect of alpha-adrenoceptor stimulation on the airways of normal and asthmatic man. Clin. Sci. Mol. Med. 54, 283–289 (1978)
Sörenby, L.: The beta-adrenoceptors of the lung mediating inhibition of antigen-induced histamine release. Eur. J. Pharmacol. 30, 140–147 (1975)
Spector, S.L., Garza, G.M.: Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: Response to albuterol, isoproterenol, and placebo aerosols. J. Allergy Clin. Immunol. 59, 280–286 (1977)
Spector, S.L., Hudson, L., Petty, T.L.: Effect of bronkosol and its components on cardiopulmonary parameters in asthmatic patients. J. Allergy Clin. Immunol. 59, 371–376 (1977)
Stanfield, C.A., Yu, P.N.: Hemodynamic effects of methoxamine in mitral valve disease. Circ. Res. 8, 859–864 (1960)
Steen, S.N., Ziment, I., Smith, R., Kuo, J.: Effect of aerosolized pirbuterol on airway conductance. Res. Clin. Pharmacol. Ther. Res. System 2, 1623 (1974)
Stjärne, L., Kaijser, L., Mathé, A., Birke, G.: Specific and unspecific removal of circulating noradrenaline in pulmonary and systemic vascular beds in man. Acta Physiol. Scand. 95, 46–53 (1975)
Stone, D.J., Zaldivar, C., Keltz, H.: The effects of very low doses of nebulized isoproterenol, nebulized saline, and intravenous isoproterenol on blood gases in patients with chronic bronchitis. Am. Rev. Respir. Dis. 101, 511 (1970)
Strandberg, K., Mathe, A. A., Yen, S.S.: Release of histamine and formation of prostaglandins in human lung tissue and rat mast cells. Int. Arch. Allergy Appl. Immunol. 53, 520–529 (1977)
Stockley, R.A., Finnegan, P., Bishop, J.M.: Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale. Thorax 32, 601–605 (1977)
Szentivanyi, A.: ß-adrenergic theory of the atopic abnormality in bronchial asthma. J. Allergy 42, 203 (1968)
Tadei, A., Geslin, P., Delhumeau, A., Victor, J., Le Douarin, L., Richard, M.: Phentolamine in treatment of acute left ventricular insufficiencies. Arch. Mal. Coeur 68, 877–885 (1975)
Tai, E., Read, J.: Blood-gas tensions in bronchial asthma. Lancet 1, 644 (1967a)
Tai, E., Read, J.: Response of blood gas tensions to aminophyline and isoprenaline in patients with asthma. Thorax 22, 543 (1967b)
Tainter, M.L.: Comparative actions of sympathomimetic compounds phenyl and substituted phenyl derivatives, non-phenylic ring compounds and aliphatic amines. Arch. Int. Pharmacodyn. Ther. 46, 192–232 (1933)
Tashkin, D.P., Meth, R., Simmons, D.H., Lee, Y.E.: Double-blind comparison of acute bronchial and cardiovascular effects of oral terbutaline and ephedrine. Chest 68, 155–161 (1975)
Taylor, S.H., Donald, K.W.: The circulatory effects of bretylium tosylate and guanethidine. Lancet 2, 389–394 (1960)
Townley, R.G., McGeady, S., Bewtra, A.: The effect of beta adrenergic blockage on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. J. Allergy Clin. Immunol. 57, 358–366 (1976)
Trautlein, J., Allegra, J., Field, J., Gillin, M.: Paradoxic bronchospasm after inhalation of isoproterenol. Chest 70, 711–714 (1976)
Triner, L., Vulliemoz, Y., Verosky, M.: Cyclic 3′5′-adenosine monophosphate and bronchial tone. Eur. J. Pharmacol. 4, 37–46 (1977)
U’Prichard, D.C., Bylund, D.B., Snyder, S.H.: (+ /−)-(3 H)Epinephrine and (−) (3H) dihydroalprenolol binding to beta 1- and beta 2-noradrenergic receptors in brain, heart, and lung membranes. J. Biol. Chem. 253, 5090–5102 (1978)
Vancrombreucq, J.C., Etien, J.L.: Effect of Sotalol on the pulmonary function of cardiac and pulmonary patients. In: Advances in beta-adrenergic blocking therapy. Sotalol. Snart, A.G. (ed.), pp. 33–37. Rome: Excerpta Medica 1974
Van der Straeton, M., Lamont, H., Pauwels, R.: Studies on the effects of MJ-9184-1 in man. Arzneim. Forsch. (Drug Res.) 28, 1191–1194 (1978)
Vane, J.R.: The release and fate of vasoactive in the pulmonary circulation. Br. J. Pharmacol. 35, 209–242 (1969)
Van Metre, T.E., Jr.: Possible adverse effects of excessive nebulized isoproterenol in status asthmatics. Trans. Am. Clin. Clinatol. Assoc. 79, 139 (1968)
Van Metre, T.E., Jr.: Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus. J. Allergy 43, 191 (1969)
Wardell, J.R., Jr., Colella, D.F., Shetzline, A., Fowler, P.J.: Studies on carbuterol (SK F 40383-A), a new selective bronchodilator agent. J. Pharmacol. Exp. Ther. 189, 167–183 (1974)
Weetman, D.F.: A review of the actions and clinical uses of ß-adrenoceptor blocking drugs. Drugs Today 7, 261–305 (1977)
Weissberg, R.M., Marian, J., Bradshaw, J., Alvarez, R.: Differences in pulmonary and cardiovascular beta receptors in the guinea pig and rabbit. J. Pharmacol. Exp. Ther. 202, 337–345 (1977)
Willey, R.F., Grant, I.W.B.: Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics. Br. J. Clin. Pharmacol. 3, 595–600 (1976)
Williams, J.F., Jr., White, D.H., Jr., Behnke, R.H.: Changes in pulmonary hemodynamics produced by isoproterenol infusion in emphysematous patients. Circulation 28, 396–401 (1963)
Wilson, W.R., Fisher, F.D., Kirkendall, W.M.: The acute hemodynamic effects of alpha-methyldopa in man. J. Chronic. Dis. 15, 907–913 (1962)
Zimmerman, H.A.: A study of the pulmonary circulation in man. Dis. Chest 20, 46–74 (1951)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Aviado, D.M., Micozzi, M.S. (1981). Systemic Pharmacology of Adrenergic Activators and Inhibitors: Effects on the Respiratory System. In: Szekeres, L. (eds) Adrenergic Activators and Inhibitors. Handbook of Experimental Pharmacology, vol 54 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67584-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-67584-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67586-7
Online ISBN: 978-3-642-67584-3
eBook Packages: Springer Book Archive